201 related articles for article (PubMed ID: 30142809)
1. Diagnostic value of diffusion-weighted magnetic resonance imaging for local and skull base recurrence of nasopharyngeal carcinoma after radiotherapy.
Wang C; Liu L; Lai S; Su D; Liu Y; Jin G; Zhu X; Luo N
Medicine (Baltimore); 2018 Aug; 97(34):e11929. PubMed ID: 30142809
[TBL] [Abstract][Full Text] [Related]
2. Differential diagnosis of nasopharyngeal carcinoma and nasopharyngeal lymphoma based on DCE-MRI and RESOLVE-DWI.
Song C; Cheng P; Cheng J; Zhang Y; Sun M; Xie S; Zhang X
Eur Radiol; 2020 Jan; 30(1):110-118. PubMed ID: 31372786
[TBL] [Abstract][Full Text] [Related]
3. Intravoxel incoherent motion MRI in differentiation between recurrent carcinoma and postchemoradiation fibrosis of the skull base in patients with nasopharyngeal carcinoma.
Mao J; Shen J; Yang Q; Yu T; Duan X; Zhong J; Phuyal P; Liang B
J Magn Reson Imaging; 2016 Dec; 44(6):1556-1564. PubMed ID: 27227674
[TBL] [Abstract][Full Text] [Related]
4. Quantitative Analysis of DCE-MRI and RESOLVE-DWI for Differentiating Nasopharyngeal Carcinoma from Nasopharyngeal Lymphoid Hyperplasia.
Yu JY; Zhang D; Huang XL; Ma J; Yang C; Li XJ; Xiong H; Zhou B; Liao RK; Tang ZY
J Med Syst; 2020 Feb; 44(4):75. PubMed ID: 32103352
[TBL] [Abstract][Full Text] [Related]
5. Differentiation between nasopharyngeal carcinoma and lymphoma at the primary site using whole-tumor histogram analysis of apparent diffusion coefficient maps.
Lian S; Zhang C; Chi J; Huang Y; Shi F; Xie C
Radiol Med; 2020 Jul; 125(7):647-653. PubMed ID: 32072391
[TBL] [Abstract][Full Text] [Related]
6. Distinguishing early-stage nasopharyngeal carcinoma from benign hyperplasia using intravoxel incoherent motion diffusion-weighted MRI.
Ai QY; King AD; Chan JSM; Chen W; Chan KCA; Woo JKS; Zee BCY; Chan ATC; Poon DMC; Ma BBY; Hui EP; Ahuja AT; Vlantis AC; Yuan J
Eur Radiol; 2019 Oct; 29(10):5627-5634. PubMed ID: 30903340
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of pretreatment tumor apparent diffusion coefficient values in nasopharyngeal carcinoma.
Yan DF; Zhang WB; Ke SB; Zhao F; Yan SX; Wang QD; Teng LS
BMC Cancer; 2017 Oct; 17(1):678. PubMed ID: 29020937
[TBL] [Abstract][Full Text] [Related]
8. Value of intravoxel incoherent motion and dynamic contrast-enhanced MRI for predicting the early and short-term responses to chemoradiotherapy in nasopharyngeal carcinoma.
Hou J; Yu X; Hu Y; Li F; Xiang W; Wang L; Wang H; Lu Q; Zhang Z; Zeng W
Medicine (Baltimore); 2016 Aug; 95(35):e4320. PubMed ID: 27583847
[TBL] [Abstract][Full Text] [Related]
9. Role of diffusion-weighted imaging in the discrimination of benign and metastatic parotid area lymph nodes in patients with nasopharyngeal carcinoma.
Chen C; Lin Z; Xiao Y; Bai P; Yue Q; Chen Y; Chen L
Sci Rep; 2018 Jan; 8(1):281. PubMed ID: 29321485
[TBL] [Abstract][Full Text] [Related]
10. Value of diffusion-weighted magnetic resonance imaging on the follow-up of nasopharyngeal carcinoma after radiotherapy.
Xu JF; Wu XW; Wang WQ; Kong LL; Wu LM; Wang F
J Xray Sci Technol; 2014; 22(5):605-12. PubMed ID: 25265921
[TBL] [Abstract][Full Text] [Related]
11. Predicting chemoradiotherapy response of nasopharyngeal carcinoma using texture features based on intravoxel incoherent motion diffusion-weighted imaging.
Qin Y; Yu X; Hou J; Hu Y; Li F; Wen L; Lu Q; Fu Y; Liu S
Medicine (Baltimore); 2018 Jul; 97(30):e11676. PubMed ID: 30045324
[TBL] [Abstract][Full Text] [Related]
12. Diffusion-weighted imaging to differentiate metastatic from non-metastatic retropharyngeal lymph nodes in nasopharyngeal carcinoma.
Li H; Liu XW; Geng ZJ; Wang DL; Xie CM
Dentomaxillofac Radiol; 2015; 44(3):20140126. PubMed ID: 25430557
[TBL] [Abstract][Full Text] [Related]
13. Combination of diffusion-weighted imaging and arterial spin labeling at 3.0 T for the clinical staging of nasopharyngeal carcinoma.
Xiao B; Wang P; Zhao Y; Liu Y; Ye Z
Clin Imaging; 2020 Oct; 66():127-132. PubMed ID: 32480267
[TBL] [Abstract][Full Text] [Related]
14. Magnetic Resonance Imaging Features on Deep Learning Algorithm for the Diagnosis of Nasopharyngeal Carcinoma.
Huang R; Zhou Z; Wang X; Cao X
Contrast Media Mol Imaging; 2022; 2022():3790269. PubMed ID: 35677026
[TBL] [Abstract][Full Text] [Related]
15. Quantitative dynamic contrast-enhanced and diffusion-weighted MRI for differentiation between nasopharyngeal carcinoma and lymphoma at the primary site.
Yu XP; Hou J; Li FP; Xiang W; Lu Q; Hu Y; Wang H
Dentomaxillofac Radiol; 2016; 45(3):20150317. PubMed ID: 26846711
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of diffusion-weighted MR imaging for nasopharyngeal carcinoma, head and neck lymphoma and squamous cell carcinoma at the primary site.
Fong D; Bhatia KS; Yeung D; King AD
Oral Oncol; 2010 Aug; 46(8):603-6. PubMed ID: 20619723
[TBL] [Abstract][Full Text] [Related]
17. In Vivo Imaging Markers for Prediction of Radiotherapy Response in Patients with Nasopharyngeal Carcinoma: RESOLVE DWI versus DKI.
Huang WY; Li MM; Lin SM; Chen F; Yang K; Zhu XL; Wu G; Li JJ
Sci Rep; 2018 Oct; 8(1):15861. PubMed ID: 30367176
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the pre-treatment functional MRI metrics' efficacy in predicting Locoregionally advanced nasopharyngeal carcinoma response to induction chemotherapy.
Zhao DW; Fan WJ; Meng LL; Luo YR; Wei J; Liu K; Liu G; Li JF; Zang X; Li M; Zhang XX; Ma L
Cancer Imaging; 2021 Nov; 21(1):59. PubMed ID: 34758876
[TBL] [Abstract][Full Text] [Related]
19. Diffusion weighted magnetic resonance imaging of pre and post treatment nasopharyngeal carcinoma.
Hirshoren N; Damti S; Weinberger J; Meirovitz A; Sosna J; Eliashar R; Eliahou R
Surg Oncol; 2019 Sep; 30():122-125. PubMed ID: 31500774
[TBL] [Abstract][Full Text] [Related]
20. [High resolution diffusion-weighted imaging for characterising nasopharyngeal carcinoma].
Wang Y; Wang GJ; Ye Y; Lu YT; Wu WH; Li SL
Zhonghua Yi Xue Za Zhi; 2017 May; 97(17):1303-1306. PubMed ID: 28482430
[No Abstract] [Full Text] [Related]
[Next] [New Search]
